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HIV-1 Nef has previously been shown to bind to Src homology-3 (SH3) domains of a subset of Src family tyrosine kinases.
In addition, Nef has been reported to coprecipitate with a serine/threonine kinase activity termed NAK (for Nef-associated
kinase). The identity of NAK remains uncertain, but it has been suggested to represent a novel member of the p21-activated
kinase (PAK) family. We report here that NAK autophosphorylation is increased not only by an activated form of the p21-family
GTPase cdc42 but also by a plasma membrane-targeted fragment of the adapter protein Nck, thus providing further evidence
that NAK is related to PAKs. A detailed structure-based mutational analysis of Nef revealed that all amino acid changes that
inhibited the Nef/Hck-SH3 interaction, as measured by surface-plasmon resonance, also abolished coprecipitation of NAK.
As PAK family proteins do not contain SH3 domains, these observations are best explained by a protein complex in which
Nef, NAK, and an SH3-protein all contact each other. In addition, a number of conserved amino acids in Nef that are not
involved in SH3 binding were also found to be crucial for association with NAK. Molecular modeling suggests that these
residues are involved in formation of an adjacent binding surface for NAK or another critical component of the NAK/Nef
complex. © 1998 Academic Press
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INTRODUCTION
Nef is a 27- to 34-kDa myristoylated protein of primate
lentiviruses that is indicated as a critical factor in devel-
opment of high viremia and AIDS but is not absolutely
required for the viral life cycle (reviewed in Harris, 1996;
Saksela, 1997). Findings on physical and functional in-
teractions between Nef and various protein kinases in-
volved in cellular signal transduction pathways have im-
plicated modulation of host cell signaling cascades as a
potentially important function of Nef (reviewed in Sak-
sela, 1997; Sawai et al., 1997).
A structural basis for a Nef/kinase-interaction was
provided by the observation that a highly conserved
amino-acid sequence in Nef, consisting of repeated pro-
line residues in a Pro-x-x-Pro configuration (PxxP motif),
can bind with high affinity to the Src homology-3 (SH3)
domain of the Src-family tyrosine kinases Hck and Lyn
(Saksela et al., 1995). Mutations that disrupt the Nef PxxP
motif abolish its ability to increase the replicative poten-
tial of HIV and block a number of effects of Nef on
cellular signaling but do not prevent Nef-induced down-
modulation cell-surface CD4 expression (Goldsmith et
al., 1995; Saksela et al., 1995; Iafrate et al., 1997). Binding
of Nef potently stimulates the catalytic activity of Hck
(Moarefi et al., 1997), and their coexpression can activate
cells and even lead to malignant transformation (Briggs
et al., 1997), suggesting a functional role for this interac-
tion in HIV-infected cells that express Hck, such as
macrophages. Although interactions between Nef and
the SH3 domains of the T-cell Src-kinases Lck and Fyn
have been noted (Lee et al., 1995; Collette et al., 1996;
Greenway et al., 1996; Arold et al., 1997), an SH3-domain
protein expressed in T lymphocytes and showing Hck-
like avid binding to Nef remains to be identified.
In contrast to the restricted expression pattern of Hck,
a 62-kDa serine kinase coprecipitating with Nef has
been demonstrated in a wide variety of cell types, includ-
ing T cells (Sawai et al., 1994, 1997). The identity of this
kinase, termed NAK (for Nef-associated kinase), has
remained unclear, but a number of observations suggest
that it may belong to the family of p21-activated protein
kinases (PAKs) (Lu et al., 1996; Nunn and Marsh, 1996;
Sawai et al., 1996). These observations include cross-
reactivity with certain anti-PAK antibodies and the acti-
vation of NAK (as evidenced by its increased autophos-
phorylation) by dominantly active forms of cdc42 and
Rac, two small p21-GTPases that regulate the PAKs (re-
viewed in Sells and Chernoff, 1997). However, it appears
that NAK represents none of the three known members
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of the mammalian PAK family (Lu et al., 1996; Nunn and
Marsh, 1996).
The structural determinants required for NAK-associ-
ation have been mapped to multiple regions in Nef, such
as a highly conserved di-arginine (RR) motif in the central
core domain of Nef (Sawai et al., 1995). Interestingly, it
has been reported that mutations disrupting the HIV-1
Nef PxxP motif also abolish coprecipitation of NAK
(Wiskerchen and Cheng-Mayer, 1996). More recently, it
was also noted that a number of amino-acid changes
within the SH3-ligand region of SIVmac239 Nef similarly
abrogate its association with NAK (Khan et al., 1998).
However, because of certain ostensibly contradictory
observations, most notably the inhibitory effect on NAK
association by mutations in the PxxP region of Nef that
are not thought to be involved in SH3 binding
(Wiskerchen and Cheng-Mayer, 1996), Nef/NAK complex
formation has been considered unrelated to the SH3-
binding function of Nef.
In this study we have performed an extensive struc-
ture-based mutational analysis of Nef, examined the
quantitative effects of these changes on the SH3-binding
capacity of Nef using a Biacore biosensor apparatus and
correlated these data with the ability of the correspond-
ing mutants to coprecipitate NAK. Based on these results
we argue that an SH3 protein plays a critical role in the
assembly of the NAK/Nef complex. In addition, a number
of other Nef residues, including some in the proline-
repeat region of the Nef polypeptide, appear to be im-
portant for NAK association by forming an adjacent but
distinct binding surface, which may be a docking site for
NAK. In addition, we provide evidence further strength-
ening the idea that NAK is indeed related to the PAK
family kinases.
RESULTS
NAK is activated by a membrane-tagged SH3 domain
of Nck
To reproduce earlier results, which demonstrated an
association of HIV-1 Nef with a cdc42-regulated cellular
kinase, we transfected human embryonic 293 cells with
expression vectors for the NL4–3 R71 Nef with or without
a dominantly active mutant of cdc42 (cdc42V12). As
shown in Fig. 1, we were able to coprecipitate using an
anti-Nef antiserum a 62-kDa protein that could be phos-
phorylated in an in vitro autokinase assay (IVKA) and in
further discussion is referred to as NAK. NAK signals
from cells transfected with R71 Nef were typically faint
and sometimes even difficult to detect over the back-
ground signal. However, cotransfection of cdc42V12 re-
sulted in a robust increase in the NAK signal (Fig. 1).
Slightly less Nef protein was seen by Western blotting in
cells transfected with Nef (plus an empty control vector)
(Fig. 1, lane A) than in cells transfected with cdc42V12
(lane C) of myrNck-SH3–2 (lane B, see discussion be-
low). However, this small difference in Nef expression
was negligible as compared to the large difference in the
NAK signal from these cells and was not observed in a
number of other experiments in which a similar increase
in coprecipitating NAK activity was seen.
To examine other possible similarities between NAK
and PAKs, we tested whether NAK can also be activated
by an Nck-SH3-mediated targeting to the plasma mem-
brane. It has previously been shown that expression of a
protein consisting of a 14-aa v-Src myristoylation motif
and the second (of three) SH3 domains of the adapter
protein Nck can activate PAK1 in 293 cells by binding to
a PxxP motif in the amino terminus of PAK1 (Lu et al.,
FIG. 1. NAK activity coprecipitating with Nef is increased by coex-
pression of a constitutively active form of cdc42 as well as a mem-
brane-targeted Nck-SH3 protein. (Top) IVKA analysis of anti-Nef immu-
nocomplexes from 293 cells transfected with 10 mg of an Nef expres-
sion vector (Nef TX: 1) or an empty control vector (Nef TX: 2) alone or
in the presence of 5 mg of expression vectors for cdc42V12 or a
myristoylated second SH3 domain of Nck (myrNck-SH3–2) or 5 mg of
the relevant empty control vector (Control). (Bottom) Anti-Nef Western
blot analysis demonstrating similar amounts of Nef protein in all im-
munocomplexes from cells transfected with Nef (corresponding lanes
in both panels marked A, B, and C.
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1997). As shown in Fig. 1, co-expression of this mem-
brane-targeted Nck-SH3 protein (myrNck-SH3–2) with
Nef also resulted in a clear increase in NAK signal in an
IVKA analysis of anti-Nef immunoprecipitates (IPs) from
the cotransfected cells. This observation suggests that
like PAK1, NAK can be activated by relocation to the
plasma membrane and that NAK also contains a func-
tional binding site for the second SH3 domain of Nck.
Because of the lack of reagents to directly detect NAK, it
was not technically feasible to formally demonstrate that
the activation of NAK was indeed due to its relocation to
the plasma membrane by myrNck-SH3–2. However, this
assumption was strongly supported by the observation
that cotransfection of an identical construct expressing a
nonmyristoylated form of Nck-SH3–2 had no effect on
NAK activity (data not shown). Since it would formally
also be possible that myrNck-SH3–2 could increase co-
precipitation of NAK by binding to and targeting Nef
(rather than NAK) to the plasma membrane, we tested
whether recombinant Nck produced in bacteria could
bind to Nef. However, under conditions when strong in
vitro binding to PAK1 was seen, no evidence of an inter-
action between Nck and Nef could be observed (data not
shown).
Thus the observations that NAK can be activated by
the p21-family GTPase cdc42 as well as by plasma mem-
brane-targeted Nck-SH3 agree with and provide new
support for the idea that NAK is a member of the PAK
kinase family.
Structure-based mutagenesis of residues in the core
domain of Nef
To examine the role of SH3-binding of Nef in associ-
ation with NAK, a number of new mutants were con-
structed into R71 Nef background (Table 1). R71 is a
derivative of the original HIV-1 NL4–3 Nef allele (termed
T71 in this study) and has an arginine residue in position
71 to mimic the sequence of most naturally occurring Nef
sequences (Shugars et al., 1993; Saksela et al., 1995). In
‘‘the resting PBMC assay’’ for Nef function, HIV strains
carrying R71 or T71 Nef alleles grow with similar wild-
type kinetics (Saksela et al., 1995). Binding of R71 Nef
with the SH3 domain of the tyrosine kinase Hck has been
previously characterized in detail (Lee et al., 1995, 1996).
This high-affinity interaction has an equilibrium dissoci-
ation constant (KD) of approximately 250 nM, measured
based on surface plasmon resonance (SPR; Biacore) and
confirmed by an independent method (isothermal titra-
tion calorimetry; KD 190 nM). In addition to the novel Nef
mutants, a previously described Nef allele with a double-
mutation affecting both of the PxxP-defining prolines
(P72A;P75A in T71 background; PA-1) was also used.
PA-1 Nef has been shown by multiple methods to have
lost all measurable affinity to Hck-SH3, and viruses car-
rying the PA-1 allele replicate with delayed kinetics iden-
tical to those of an isogenic Nef(2) strain (Saksela et al.,
1995).
The classification of the mutations engineered based
on the available Nef/SH3 cocrystal and Nef NMR struc-
tures (Lee et al., 1996; Grzesiek et al., 1997) is shown in
Table 1, and the rationale behind constructing these is
explained in the following. Mutations in category B in-
volve residues that constitute the minus-orientation SH3
ligand consensus sequence PXØPXR, in which X is any
amino acid, and Ø is a (typically small) hydrophobic
residue (Feng et al., 1994; Lim et al., 1994). This pattern is
conserved in the vast majority, if not all, available HIV-1
Nef sequences and corresponds to the residues
P72Q73V74P75L76R77 in T71 and R71. In the Nef/SH3 co-
crystal (Lee et al., 1996), as well as in structures of a
number of linear peptides complexed with their cognate
SH3 domains (for a review, see Mayer and Gupta, 1998),
these consensus residues make important contacts with
the PPII helix-accommodating binding surface of SH3. By
contrast, although located in the PPII helix region of Nef,
the mutated residues in category C are not part of the
SH3-ligand consensus sequence and occupy positions
that are not intimately involved in SH3 binding. The
double mutant Q73P;L76A carries a change in both of the
residues within the Nef PxxP motif, which are not pre-
dicted to be critical for SH3 binding. The P69A mutant
was made because this change, which affects a residue
immediately adjacent to the SH3-binding site of Nef, has
been previously reported to abolish NAK binding
(Wiskerchen and Cheng-Mayer, 1996).
The F90R mutation in category D was engineered
based on the structure of the Nef/SH3 complex (Lee et
al., 1996). Although the Phe90 residue is relatively distant
from the canonical PxxP/SH3 contact region, this change
was predicted to affect binding of Nef to Hck, and prob-
ably also to other SH3 domains, because of the impor-
tant role of Phe90 in coordinating a tertiary (non-PxxP)
interaction between Nef and the SH3 domain RT-loop
(Lee et al., 1996; Lim, 1996). Finally, the mutations in the
TABLE 1
HIV-1 Nef Variants Used in This Study
Category Variant
A Parental pNL4-3 Nef (T71) and its “wild-type”
derivative: R71 T71, R71
B Changes in SH3-contacting PxxP-motif residues
in the PPII helix region: P72A, P75A, P72A;
P75A (PA-1), V74D, R77E, V74D;R77E
C Changes in non-SH3-contacting residues in the
PPII helix region: P69A, Q73P;L76A
D Changes in SH3-contacting residues outside of
the PPII helix F90R
E Changes in non-SH3-contacting residues
outside of the PPII helix: R106A, L112R,
F121R
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category E involve residues that are not located in the
PPII helix region nor have been implicated in SH3 bind-
ing. These mutations were made either because of pub-
lished inhibitory effects on NAK association (R106A)
(Sawai et al., 1995; Wiskerchen and Cheng-Mayer, 1996)
or guided by our initial results on inhibition of NAK
binding by mutations in category C.
Effect of mutations in Nef on association with Hck-
SH3
To quantitatively assess the SH3-binding capacity of
the different modified forms of Nef, we produced these
in E. coli as glutathione-S-transferase (GST) fusion
proteins and examined by a Biacore biosensor appa-
ratus their binding to the Hck SH3 domain, a known
high-affinity ligand for Nef. Hck-SH3 was produced in
bacteria fused to the maltose-binding protein (MBP) to
avoid artifacts arising from GST homodimerization. For
the same reason, GST was removed from the Nef
proteins by thrombin cleavage before SH3-binding
analysis to avoid possible GST-directed complex for-
mation on top of Nef-SH3 heterodimers on the biosen-
sor chip. The completeness of this cleavage, as well
the spectrophometrically estimated Nef protein con-
centrations, were confirmed by SDS–PAGE before the
Biacore analysis (data not shown). The MBP-SH3 pro-
tein was biotinylated and attached to a streptavidin-
coated biosensor chip to give a relatively high MBP-
SH3 surface density. The second channel on the same
biosensor chip was coated with an equal molar
amount of similarly biotinylated plain MBP. The in-
jected Nef proteins passed through both of these
channels, and the bulk refractive index effects on the
SPR signal recorded on the MBP-only channel (in
FIG. 2. Biacore analysis of the effects of mutations in Nef on binding to Hck-SH3. (A) An overlay of sensorgrams of specific SPR signals (cRU; bulk
refractive index effects recorded on a parallel control channel have been subtracted) illustrating association and dissociation of R71 Nef protein (analyte)
to Hck-SH3 (ligand) immobilized on a biosensor chip. The time point zero corresponds to the start of six different injections of twofold serial dilutions of R71
Nef ranging from 4.0 (top) to 0.125 mM (bottom). Part of the slow dissociation phase starting after the end of the 20-min (1200-s) Nef injection can also be
seen. (B) A Scatchard plot analysis for estimating the equilibrium dissociation constants (KD) for three different Nef variants (R71, T71, and F90R) based on
SPR data obtained as shown in (A) for R71 Nef. The corrected relative resonance unit values (cRU) of each protein dilution at the end of the 20-min injection
were plotted as shown, and the affinity of the interaction was estimated from the slope of the line that best fitted to these data points. The coefficients for
determination (R2) for these analyses, together with the complete data on all the Nef variants tested are shown in Table 2.
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which no binding was observed) were subtracted from
the RU values of the MBP-Hck channel (shown in Fig.
2A for R71 Nef).
As noted before (Lee et al., 1995), the association
rate of R71 Nef with Hck-SH3 was too rapid to be
reliably estimated from the shape of the SPR curve,
and the affinities (equilibrium dissociation constants;
KD) of the Nef/SH3 interactions were therefore derived
by Scatchard analyses of the cRU values at the end of
a long injection of serial twofold dilutions of the Nef
proteins. The primary SPR data (sensorgrams) regard-
ing such serial injections of R71 Nef are shown as an
overlay plot in Fig. 2A. These curves appear very
similar to the sensorgrams we have previously re-
corded using an R71 Nef preparation that was highly
purified for crystallographic purposes. The KD values
(260 nM) derived from the Scatchard analysis of the
R71 Nef data in Fig. 2B also agree well with the
affinities previously recorded based on SPR (250 nM)
and ITC (190 nM), thus validating the present experi-
mental approach.
Figure 2B shows a composite of Scatchard plots
based on the R71 Nef sensorgrams (Fig. 2A) together
with similar data on T71 and F90 Nef. A summary of all
Biacore experiments and the KD values obtained are
presented in Table 2. As predicted by previous struc-
tural studies, the Arg71 residue in R71 Nef contributes
to the high affinity of its interaction with Hck-SH3 (KD
260 in the present study), as indicated by the threefold
lower affinity measured for T71 Nef (KD 810 nM). Al-
though, we haven’t noted a significant difference in the
replicative potential of HIV strains carrying the R71 vs
T71 Nef alleles in the available cell culture assays
(Saksela et al., 1995), it is possible that under some
conditions the more avid SH3 binding of the ‘‘patient-
like’’ R71 Nef provides such viruses a growth advan-
tage over viruses resembling the original HIV-1 NL4–3
strain (T71) in this regard.
As seen in various instances before (Lee et al., 1995;
Saksela et al., 1995), the PA-1 mutant showed no mea-
surable SH3-binding affinity (Table 2). Change of either
one of the PxxP-defining proline residues alone into an
alanine (P72A or P75A) also resulted in a large reduction
in binding affinity but did not completely abolish binding
to Hck-SH3 (Table 2). The residual binding of these
single-proline mutants (KD 4.18 mM for P72A and KD 5.12
mM for P75A) was not surprising considering the multiple
stabilizing non-PxxP interactions between Nef and Hck-
SH3 and that another hydrophobic residue was used to
replace the prolines. The Nef residue Phe90 plays an
important role in the aforementioned non-PxxP interac-
tions by participating in accommodation of the SH3 RT-
loop (Lee et al., 1996; Lim, 1996). Accordingly, the F90R
mutation decreased binding to Hck-SH3 almost 10-fold
(KD 1.99 mM). Also, in good agreement with the current
structural understanding on SH3/PxxP binding, replace-
ment of either the hydrophobic (V74D) or the positively
charged (R77E) residue in the PxxP-consensus se-
quence of Nef with an acidic residue completely abol-
ished SH3 binding (Table 2). Thus as also indicated by
the PA-1 mutation, the stabilizing tertiary (non-PxxP) in-
teractions are not sufficient to mediate SH3 binding in
the absence of a functional PxxP motif.
In contrast to the inhibitory mutations described
above, changes involving residues in the PPII helix re-
gion of Nef that were not predicted to participate in SH3
binding (P69A and Q73P;L76A) did not decrease, or even
improved, the affinity toward Hck-SH3. The slight in-
crease in SH3 binding of the Q73P;L76A mutant may be
due to stabilization of the PPII fold conformation in the
PxxP-region of Nef and highlights the fact that these
nonconsensus residues do not directly participate in
SH3 binding. As expected, mutations located outside of
the PPII helix region and affecting residues that have not
been implicated in SH3 binding by structural studies did
TABLE 2
Summary of SPR Studies on SH3 Binding of Nef Variants
Nef
protein
Category
in Table 1
Concentration
range (mM)
Number of
data points
Coefficient of
determination (R2)
Affinity
KD (mM)
R71 A 4.0–0.125 6 0.97 0.26
T71 A 4.0–0.125 6 0.93 0.81
P72A B 4.0–1.0 3 0.99 4.18
P75A B 4.0–1.0 3 0.94 5.12
P72A;P75A B 4.0 1 — —
V74D B 4.0 1 — —
R77E B 4.0 1 — —
F90R C 4.0–0.50 4 0.99 1.99
P69A D 4.0–0.125 6 0.95 0.22
Q73P;L76A D 4.0–0.125 6 0.97 0.18
R106A E 4.0–0.25 5 0.97 0.28
F121R E 4.0–0.125 6 0.99 0.32
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not significantly interfere with the interaction of these
variants (R106A, L112R, and F121R) and Hck-SH3.
Effect of mutations in Nef on coprecipitation of NAK
To examine the dependence of NAK association on
SH3-binding capacity of Nef we cotransfected all the Nef
variants listed in Table 1 into 293 cells together with the
NAK-activating myristoylated Nck-SH3 protein (myrNck-
SH3–2). We chose to use myrNck-SH3–2, instead of
cdc42V12 for enhancing the NAK signals because it ap-
peared to be a more specific activator of NAK. In pro-
longed exposures of IVKA gels of anti-Nef IPs, we typi-
cally observed a phosphoprotein comigrating with NAK
in cells transfected with cdc42V12 but not expressing Nef
(faintly visible in Fig. 1), probably representing a nonspe-
cifically precipitating abundant kinase regulated by
cdc42. However, when NAK was activated by myrNck-
SH3–2, this NAK-sized phosphoprotein was not ob-
served even in very long exposures, unless the 293 cells
were also transfected with Nef (Fig. 3 and data not
shown), thus providing a clean system for evaluation of
the inhibitory effects of the different mutations intro-
duced in Nef.
As evident from Fig. 3, all Nef mutants that failed to
bind to Hck-SH3 (PA-1, V74D, and R77E) were also com-
pletely negative for NAK association. Also, no NAK could
be coprecipitated with the single-proline Nef mutant
P75A. A faint NAK signal could in most experiments be
observed in P72A-Nef-transfected cells in accord with its
slightly better SH3-binding capacity (see Table 2). Also,
the threefold decrease in the SH3-binding capacity of
T71 Nef was proportionally reflected by a similar dimi-
nution in the amount of coprecipitating NAK signal. In-
stead, F90R Nef, a mutant with low but apparent SH3-
binding potential, was negative for NAK association. It
should be noted, however, that since the Phe90 residue is
not part of the idiotypic PxxP/SH3 interface of Nef, mu-
tation in this residue could affect binding of another SH3
domain even more severely than that of Hck. In conclu-
sion, we found that without exception, mutations that
affected SH3 binding of Nef also resulted in decreased
or abrogated NAK association.
As expected from the literature, no NAK association
was seen in cells transfected with the R106A Nef mutant
(Sawai et al., 1995; Wiskerchen and Cheng-Mayer, 1996).
In our hands this mutant had a slightly decreased sta-
bility (see Western blot in Fig. 3) as compared to the
other Nef variants tested but was clearly expressed in
sufficient levels to allow the conclusion that it suffered
from a specific defect in NAK binding. Also in agreement
with published data (Wiskerchen and Cheng-Mayer,
1996), the P69A mutant was equally negative for NAK
association. A similar result was also seen with the
double-mutation affecting the two nonconsensus resi-
dues within the PxxP motif of Nef (Q73P;L76A).
To understand why the P69A and Q73P;L76A Nef pro-
teins did not associate with NAK, despite their undimin-
ished ability to bind to Hck-SH3 (Table 2), we carefully
examined the atomic organization of this region in the
Nef/SH3 cocrystal and Nef NMR structures (Lee et al.,
1996; Grzesiek et al., 1997). Both Gln73 and Leu76 are on
the surface of the core domain of Nef, even when it is
bound to an SH3 domain (Fig. 4). Together with the
neighboring residues provided by the a-helical part of
Nef (such as Phe121 and Leu112), Gln73 and Leu76 form an
exposed surface, which could well serve as an interac-
tion site for NAK (or another necessary component of the
NAK/Nef/SH3 complex). Pro69 can not be seen in the
available Nef/SH3 cocrystal structures (Lee et al., 1996;
Arold et al., 1997), and its position is relatively variable
among the 40 calculated structures from which the NMR
model of Nef was derived (Grzesiek et al., 1997). How-
ever, it is the most amino-terminal residue of the well-
ordered core domain of Nef and is probably important for
providing a correct backbone angle to properly position
the residues extending further toward the amino termi-
FIG. 3. Effect of different Nef mutations on NAK/Nef complex forma-
tion. Ten micrograms of expression vectors for each of the indicated
wild-type or mutant forms of Nef were transfected into 293 cells to-
gether with the NAK-activating myr-Nck-SH3–2. Equal amounts of pro-
tein lysates normalized for their protein concentration were subjected
to anti-Nef immunoprecipitation, followed by IVKA (top) or anti-Nef
Western blotting (bottom). The order and numbering of the lanes are the
same in both panels. In lane 1 an empty vector without a Nef-insert was
transfected as a control.
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nus, which in turn, may be important for allowing NAK to
bind (see Discussion)
To experimentally test the idea that the surface in Nef
adjacent to the SH3-binding region would be important
for NAK binding, as hypothesized above, we produced
mutations in the residues Leu112 (L112R) and Phe121
(F121R), thus bringing positive charge to this hydropho-
bic region, which on one side is neighbored by Gln73 and
Leu76 and on the other side by a negatively charged
patch formed by three highly conserved aspartate resi-
dues (Asp108, Asp111, and Asp123) (Fig. 4). In agreement
with our model, both of these new Nef variants (F121R
and L112R) were also completely defective in binding to
NAK.
DISCUSSION
In this study we show that a cellular SH3-protein is
likely to play a critical role in association of HIV-1 Nef
with a kinase known as NAK. In addition, by demonstrat-
ing that a plasma-membrane targeted Nck-SH3 protein
can activate NAK, we provide further evidence that this
kinase is a member of the PAK family.
Since the known PAKs do not contain SH3 domains, it
appears likely that the NAK/Nef complex contains an
additional SH3-containing protein. The Nck adapter pro-
tein would be an attractive candidate for this role, as we
found that it can interact with NAK via its second SH3
domain and contains two additional SH3 domains that
could bind to the SH3-ligand site in Nef. However, we
have not been able to show any affinity between a
recombinant full-length Nck and Nef, suggesting that
another protein, perhaps similar to Nck, is serving this
function.
We confirmed the previously reported finding
(Wiskerchen and Cheng-Mayer, 1996) that mutation of
the Pro69 residue, which precedes the PPII helix region
of Nef but is not a component of the SH3-ligand motif,
also resulted in a loss of NAK association. Pro69 is in a
position where it is likely to govern the orientation of the
region located amino-terminally relative to the Nef core
domain (see Fig. 4). Thus careful coordination of the
positioning of this region appears to be important for
NAK association. If misplaced, these residues could in-
terfere with the interaction of NAK and its adjacent pu-
tative binding surface. Alternatively, the residues in this
region might fold to form a part of this putative NAK-
binding surface. The latter possibility (active participation
of the region amino terminal to the PPII helix) appears
more likely in the light of the results of a deletion analysis
undertaken by Sawai et al. (1995). They reported that
while the first 44 amino acids of HIV-1 SF2 Nef could be
deleted without losing NAK binding, provided that mem-
brane-targeting of Nef was preserved, but extension of
the deletion to the SF2 Nef Val70 residue (corresponding
to Val66 in R71) resulted in a complete loss of NAK
coprecipitation. Thus although it is not possible to con-
clude with certainty which residues in Nef are directly
contacting NAK, our results suggest that a complex bind-
ing surface contributed by Gln73, Leu76, Leu112, and
Phe121 (Fig. 4), and possibly residues located between
FIG. 4. Putative NAK binding site on the surface of Nef. Surface
presentation of the core regions of Nef bound to an SH3 domain (green
ribbon). The corresponding parts of the crystal (Lee et al., 1996) and
NMR (Grzesiek et al., 1997) structures were superimposed to position
the SH3 domain correctly. Residues mutated and found to affect NAK
binding are shown in yellow and indicated by one-letter symbols (P69,
L76, L112, and F121) on the surface of Nef. Three aspartates (residues
108, 111, and 123; colored red) form a negatively charged patch around
residues Leu112 and Phe121. Changing the latter into arginines (in L112R
and F121R mutants) therefore alters the electrostatic properties of this
surface. Note that although the Gln73 and Leu76 residues are compo-
nents of the peptide backbone of the SH3-binding PPII helix, their
hydrophobic side chains extend away from the SH3 domain sitting on
the other side of Nef and participate in formation of the putative
NAK-binding surface. Other Nef residues that can also be seen to
contribute to this hydrophobic surface patch (Tyr115, His116, and Pro122)
but were not targeted by mutagenesis in this study are indicated by
gray color. The exact positions of Pro69 and the residues aminoterminal
to it (the ‘‘arm-like’’ structure below P69) are not well defined by the
available structural data. However, as discussed in the text, the role of
Pro69 in associating with NAK is more likely to be the positioning of the
Nef amino terminus, rather than direct involvement in accommodating
NAK.
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the positions 40 and 69 in the Nef polypeptide, may be
involved.
Identification of the SH3-protein involved in the NAK/
Nef complex, and of course, molecular characterization
of NAK itself represent important goals to better under-
stand the role of NAK in HIV infection. The fact that NAK
has remained unidentified so far might be related to the
multiprotein nature of the cellular NAK/Nef complex, in
which direct interactions between these two proteins
might be weak and therefore difficult to detect in simpli-
fied experimental systems. Our observation that an SH3
domain of Nck can interact with NAK could provide a
useful new approach for cloning this elusive kinase. On
a cautious note, however, it may be worth pointing out
that, although the current and previous data clearly dem-
onstrate that NAK is regulated like a PAK, and despite the
apparent cross-reactivity of certain anti-PAK antisera
with NAK (Nunn and Marsh, 1996; Sawai et al., 1996), it
may still not be possible to formally exclude the possi-
bility that NAK could also be an unrelated downstream
kinase, regulated by one of the known PAKs.
The relevance of NAK for the virulence of HIV or SIV is
currently not clear. The study by Wiskerchen and Cheng-
Mayer (1996) concluded, based on mutations affecting
the RR and PxxP motifs, as well as other residues (such
as Pro69), that NAK association is important for Nef-
induced infectivity enhancement of HIV-1 particles in a
single-round infection assay, by observing an intermedi-
ate phenotype between that of Nef(1) and Nef(2) HIV-1
strains. In contrast, it has been reported, based on trans-
fer of a NAK-negative phenotype into SF2 Nef by substi-
tuting its carboxyl-terminal third with a sequence from
another molecular clone of HIV-1, that NAK binding would
be dispensable for Nef function in the same assay (Luo
et al., 1997).
Luciw and colleagues have addressed the pathophys-
iologic relevance of the Nef/NAK complex by infecting a
large number of rhesus macaques with SIV strains car-
rying mutations in the double-arginine motif (RR-to-LL)
(Sawai et al., 1996) or in the PxxP motif (PxxP-to-AxxA)
(Khan et al., 1998). In both cases, the infection of most
animals initially closely resembled that by a Nef-deleted
strain, and high viral loads and disease progression
seen later in some animals were associated with geno-
typic and phenotypic (NAK positive) reversion of the
mutations. However, it is easy to imagine how the effects
of these mutations on Nef function could be more pleio-
tropic than anticipated. On the other hand, contradicting
results were observed in another study, which reported
disease progression in two macaques before a signifi-
cant proportion (.10%) of the input virus showed rever-
sions of the PxxP-to-AxxA mutations in their Nef genes
(Lang et al., 1997). Furthermore, it is not clear how di-
rectly the results from the SIV/rhesus macaque model
can be applied to the role of Nef in the pathogenesis of
HIV-1 infection. For example, it has been noted in studies
addressing the effects of Nef on cellular signal transduc-
tion pathways that HIV-1 Nef is functionally more strictly
dependent on its PxxP motif than SIV Nef (Iafrate et al.,
1997).
Nevertheless, despite such contradictory observa-
tions, it can be concluded that NAK association repre-
sents a potentially important property common to many
divergent Nef isolates and a possible link to important
cellular signaling cascades and therefore clearly war-
rants more a detailed characterization by future investi-
gations.
MATERIALS AND METHODS
Cells and DNA transfection
293T, a human embryonic kidney fibroblast-derived
cell line (ATCC), was grown in Dulbecco’s modified Ea-
gles’s medium (DMEM, Hyclone) containing 10% fetal
calf serum (FCS), 2 mM L-glutamine, and 100 units/ml of
penicillin and streptomycin. Plasmid DNA to be trans-
fected was mixed with 62 ml of 2 M CaCl2 and sterile
water up to 500 ml. An equal volume of 23 HEPES
solution [280 mM NaCl, 1.5 mM Na2HPO4, 55 mM N-2-
hydroxyethylpiperazine-N9-2-ethanesulfonic acid (HEPES),
pH 7.0] was added, followed by immediate dispersed
onto 293 cells (splitted 1:3 24 h earlier) growing in com-
plete medium on a 10-cm dish. Fresh medium was
changed for the cultures 16 h after the transfection.
Plasmids and mutagenesis
The eukaryotic expression plasmids for the previously
described (R71, T71, PA-1; Saksela et al., 1995) or new Nef
mutants were all constructed by inserting Nef allele
sequences between the EcoRI and SalI sites of the
CMV-driven vector pcDNA3 (Invitrogen). The new mutant
alleles were derived by standard PCR-based techniques
using Pfu polymerase (Stratagene) and specific oligonu-
cleotides (Gibco-BRL) and confirmed by sequencing (ABI
Prism 310). The MBP-Hck-SH3 plasmid was made by
inserting a fragment encoding for a 56-aa Hck polypep-
tide fragment (starting: IVVA . . . , ending: . . . VDSL) into
pMAL-S, a modified version of pMAL-c2 (New England
Biolabs) with Stop codons after the polylinker. Plasmids
for expression of cdc42V12, Nck, myrNck-SH3–2 have
been described before (Lu et al., 1997).
Recombinant protein production
Expression and purification of GST and MBP fusion
proteins in Escherichia coli BL21 were carried out as
suggested by the suppliers of these systems (Pharmacia
and New England Biolabs, respectively). After specific
elution from their respective affinity beads, the fusion
proteins were concentrated and changed into the de-
sired buffers by successive rounds of microconcentra-
tion using Centrex UF2 columns (Schleicher & Schuell).
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The buffer of the GST-Nef proteins was changed to HBS
(10 mM HEPES, pH 7.4; 150 mM NaCl; 3 mM EDTA)
containing 0.005% (v/v) surfactant P20 and 1 mM dithio-
treitol (DTT), (HBS-plus) in which they were subjected to
thrombin cleavage (1 U thrombin/0.2 mg fusion protein)
for 4–6 h at 37°C in HBS. The MBP proteins were bio-
tinylated using the EZ-Link Sulfo-NHS-LC-Biotin reagent,
as suggested by the manufacturer (Pierce), except for
using less biotin (molar ratio of protein:biotin was 1:2),
and subjected to multiple additional rounds of microcon-
centration to remove any free biotin.
Biacore measurements
Surface plasmon resonance (SPR) experiments were
carried out using a Biacore X apparatus (Pharmacia
Biosensor, Uppsala). An SA biosensor chip (Pharmacia
Biosensor) with pre-immobilized streptavidin was coated
with biotinylated MBP (to the reference channel) or MBP-
Hck-SH3 (to the test channel) proteins (100 ng/ml in
HBS-plus) by serial short injections (flow rate of 5 ml/
min). The attachment of the ligands was monitored by
the changes in the refractive index and was set to ;2200
(MBP-Hck-SH3) and ;2000 (MBP) response units (RU),
corresponding to the relative difference in their molecu-
lar weights. After immobilization of the biotinylated li-
gands, the chip was subjected to three rounds of prere-
generation cycles, which were subsequently applied
once between each Nef injection. One regeneration cy-
cle consisted of successive 1-min pulses (flow rate of 5
ml/min) of pH 2.2 glycine buffer, 0.05% SDS, and 4 M
urea. Some loss of the refractive index was observed
during the first and the second cycles but no longer
during the third cycle of this preregeneration treatment.
The injections of different Nef protein were done using
concentrations ranging from 4.0 to 0.0125 mM, with a flow
rate of 5 ml/min at 25°C in HBS-plus. Each chip was used
for approximately 50 Nef injections, during which no loss
of the immobilized ligand or the capacity of the chip to
bind to a standard solution of R71 Nef was observed. The
sensorgrams, in which the refractive index values from
the reference channel were subtracted [to give corrected
relative resonance units (cRU)], were analyzed using
BIAevaluation (v3.0) software (Pharmacia Biosensor).
The Scatchard plots and line fitting was done with Excel
(Microsoft) and were based on values from the sensor-
grams at a 20-min postinjection timepoint.
Immunoprecipitation, IVKA, and Western blotting
The sheep polyclonal anti-Nef antiserum was kindly
provided by Mark Harris (University of Leeds, UK).
Mouse monoclonal anti-Nef antibodies (2A3, 3A2, 6.2,
2H12, 3E6, 3F2.1, 3D12, and 2F2) directed against differ-
ent regions of Nef were kindly provided by Kai Krohn
from our institute. The rabbit polyclonal anti-PAK anti-
body (N-20) raised against the N-terminal region of rat
PAK1 was purchased from Santa Cruz Biotechnologies
Inc. (Santa Cruz, CA).
Forty-eight hours after transfection the cells were
washed once with ice-cold phosphate-buffered saline
(PBS) and lysed in kinase assay lysis buffer (50 mM
HEPES, pH 7.4; 150 mM NaCl; 10% glycerol; 1% Triton
X-100; 1 mM EGTA; 1.5 mM MgCl2; 10 mM NaF; 1 mM
sodium orthovanadate; 1 mM phenylmethyl-sulfonyl flu-
oride (PMSF); and 10 mg/ml approtinin). Three microliters
of the anti-Nef serum or 0.3 mg of the anti-PAK antibody
was incubated with the lysates (1 mg of total cellular
protein) for 2 h at 14°C, followed by 30-min agitation in
the presence of protein A–Sepharose beads (Sigma).
The beads were subsequently washed three times with
kinase assay lysis buffer and splitted for IVKA and im-
munoblotting.
For IVKA, the beads were subjected to two additional
washes with IVKA buffer (50 mM HEPES, pH 7.4, and 5
mM MgCl2).
32[P]-g-ATP (2.5 mCi) was added to the
bead-bound immunocomplexes (in 100 ml of IVKA buffer)
and incubated at 137°C for 20 min. The beads were
washed with ice-cold PBS and boiled for 2 min in SDS–
PAGE sample buffer. The phosphorylated proteins were
separated by SDS–PAGE, and visualized by autoradiog-
raphy.
For immunoblotting, the beads were boiled in Laemmli
sample buffer, the associated proteins separated by
SDS–PAGE, and transferred onto nitrocellulose mem-
branes. The membranes were blocked for 45 min in
PBS–Tween (PBS containing 0.05% Tween 20), plus 3%
bovine serum albumin (BSA), and 0.05% NaN3, followed
by a 2-h incubation with a mixture of monoclonal mouse
anti-Nef antibodies in PBS–Tween. After three washes
with washing buffer (PBS plus 0.2% Tween 20), the mem-
branes were incubated for 30 min with 1:3000 anti-
mouse IgG (DAKO) in PBS–Tween, washed three times,
incubated for 20 min with streptavidin-conjugated horse-
radish peroxidase (Amersham) diluted 1:5000 in PBS–
Tween, washed three times again, and developed by
ECL (Amersham) according to manufacturer’s instruc-
tions.
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